Search

Your search keyword '"Perin, T"' showing total 236 results

Search Constraints

Start Over You searched for: Author "Perin, T" Remove constraint Author: "Perin, T"
236 results on '"Perin, T"'

Search Results

1. Sixty-Day Mortality Among 520 Italian Hospitalized COVID-19 Patients According to the Adopted Ventilatory Strategy in the Context of an Integrated Multidisciplinary Clinical Organization: A Population-Based Cohort Study

2. Results from a large single institute experience of targeted intraoperative radiotherapy (TARGIT-IORT) as partial breast irradiation modality

3. Machine learning using the extreme gradient boosting (XGBoost) algorithm predicts 5-day delta of SOFA score at ICU admission in COVID-19 patients

4. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

6. Palladium(II)-η3-Allyl Complexes Bearing N-Trifluoromethyl N-Heterocyclic Carbenes: A New Generation of Anticancer Agents that Restrain the Growth of High-Grade Serous Ovarian Cancer Tumoroids

7. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

12. Recurrent diploid biparental mole

14. Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer

17. Central review of discordant samples for microarray based on ER, PR, and HER2 and local IHC/FISH assessment worldwide from 827 patients

18. High Concordance for Microarray Based Determination of ER,PR and HER2 Receptor Status and Local IHC/FISH AssessmentWorldwide in 749 Patients

19. Biobanking Management in a Cancer Center

20. Exocrine-endocrine modulation in common gastric carcinomas

21. How the 70-gene tumour expression profile 'MammaPrint' can assist in St Gallen 2009 treatment recommendations in 12 Italian hospitals

22. THE 70-GENE EXPRESSION PROFILE FOR BREAST CANCERPATIENTS IN ITALIAN HOSPITALS

23. Carcinoma of the uterine cervix with squamous and sebaceous differentiation

28. Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway

30. Improved Natural Killer cell activity and retained anti-tumor CD8+ T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy

32. [The pathology spectrum of AIDS-related non-Hodgkin's lymphoma]

33. Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen

34. KSHV/HHV-8(+) primary effusion lymphoma associates with CD138/syndecan-1 and other plasmacell-specific markers: Histogenetic and pathogenetic implications

36. Selecting for BRCA1 testing using a combination of homogeneous selection criteria and immunohistochemical characteristics of breast cancers

40. P5-11-09: High Concordance for Microarray Based Determination of ER, PR and HER2 Receptor Status and Local IHC/FISH Assessment Worldwide in 749 Patients.

41. P3-14-25: Neoadjuvant Trastuzumab and Paclitaxel Combination Induces a High Rate of Pathological Complete Responses in Locally Advanced Breast Cancer by Exploiting Host Antitumor Immunity.

43. Immunologic profiling and clinical outcome in HER2+ breast cancer patients treated in a neoadjuvant phase II study: A step forward to understand trastuzumab activity.

48. Improved Natural Killer cell activity and retained anti-tumor CD8+ T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.

Catalog

Books, media, physical & digital resources